Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network
Front Immunol. 2025 Oct 8;16:1667249. doi: 10.3389/fimmu.2025.1667249. eCollection 2025. ABSTRACT OBJECTIVE: To integrate pharmacovigilance and network pharmacology methods for a comprehensive analysis of the potential …